Product helpful for improving oral mucosa-related fibrosis

HK40137450APending Publication Date: 2026-09-11GUANGDONG HENGQIN XINCHUANGYI BIOPHARMACEUTICAL CO LTD +3
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62026125884
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-06
Filing Date
2026-07-08
Publication Date
2026-09-11

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

There is provided a product helpful to ameliorate fibrosis associated with oral mucosa, the product comprising lysozyme. It is found for the first time that lysozyme has a remarkable improvement effect on oral mucosa related fibrosis. Compared with common anti-inflammatory drugs such as glucocorticoid at present, the product has a better improvement effect. Meanwhile, the lysozyme is high in safety, can be used as both medicine and food, and has a good application prospect in the aspect of improving fibrosis related to oral mucosa.
Need to check novelty before this filing date? Find Prior Art

Description

(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202580002646.X (22) Application Date 2025.04.28 (66) Domestic Priority Data 202410550076.5 2024.05.06 CN (85) PCT International Application Entering National Phase Date 2025.11.14 (86) PCT International Application Application Data PCT / CN2025 / 091747 2025.04.28 (87) PCT International Application Publication Data WO2025 / 232624 ZH 2025.11.13 (71) Applicant Guangdong Hengqin Xinchuangyi Biomedical Co., Ltd. Address 519031 Office 507, Building 8, No. 2333 Gang'ao Avenue, Hengqin New District, Zhuhai City, Guangdong Province Applicant: Xiangbei Wellman Pharmaceutical Co., Ltd. Guangzhou New Creative Biomedical Co., Ltd. Guangzhou New Creative Wing Pharmaceutical R&D Co., Ltd. (72) Inventor: Sun Tianyu (74) Patent Agency: Guangzhou Jiaquan Patent & Trademark Agency Co., Ltd. 44205 Patent Attorney: Xue Jianqiang (51) Int.Cl. A61K 38 / 47 (2006.01) A61P 1 / 02 (2006.01) A23L 33 / 18 (2016.01) (54) Invention Title: Product that helps improve oral mucosa-associated fibrosis (57) Abstract: A product that helps improve oral mucosa-associated fibrosis is provided, the product containing lysozyme. Lysozyme has been found for the first time to have a significant improving effect on oral mucosa-associated fibrosis. Compared with commonly used anti-inflammatory drugs such as glucocorticoids, this product has a better improving effect. Meanwhile, lysozyme has high safety and can be used both as medicine and food, showing great promise in improving oral mucosa-associated fibrosis. CN 121311238 A 2026.01.09 CN 1 21 31 12 38 A